Refind
The New York Times

Key takeaways from The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.

View original

211
Made me smarter
Read later
Edit
Share
Most highlighted
Dr. Doblin’s quest to win mainstream acceptance of psychedelics took a significant leap forward on Monday when the journal Nature Medicine published the results of his lab’s study on MDMA
Your notes & highlights

  Save highlights in Reader View or with our Chrome extension.

This your link? Claim it

Get smarter every day.
About RefindDeep DivesTopicsHashtagsHelpLegal
PublishersCuratorsCross-promotionSponsors
© 2022 Refind Inc.
Apple App StoreGoogle Play StoreChrome Web Store
×

Get smarter every day

Every day we pick 7 links from around the web for you, tailored to your interests.

Or sign in with Twitter or Google


Have an account? Sign in

×

Get smarter every day

Every day we pick 7 links from around the web for you, tailored to your interests.

Or sign in with Twitter or Google


Not on Refind yet? Sign up

×

Share link

https://refind.com/links/103911418